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Abstract. There is a need to modernise clinical brachytherapy dosimetry measurement beyond 
traditional point dose verification to enable appropriate quality control within 3D treatment 
environments. This is to keep pace with the 3D clinical and planning approaches which often 
include significant patient-specific optimisation away from ‘standard loading patterns’. A 
multi-dimension measurement system is required to provide assurance of the complex 3D dose 
distributions, to verify equipment performance, and to enable quality audits. However, true 3D 
dose measurements around brachytherapy applicators are often impractical due to their 
complex shapes and the requirement for close measurement distances. A solution utilising an 
array of radiochromic film (Gafchromic EBT3) positioned within a water filled phantom is 
presented. A calibration function for the film has been determined over 0 to 90Gy dose range 
using three colour channel analysis (FilmQAPro software). Film measurements of the radial 
dose from a single HDR source agree with TPS and Monte Carlo calculations within 5 % up to 
50 mm from the source. Film array measurements of the dose distribution around a cervix 
applicator agree with TPS calculations generally within 4 mm distance to agreement The 
feasibility of film array measurements for semi-3D dosimetry in clinical HDR applications is 
demonstrated. 
1.  Introduction 
Brachytherapy treatments are currently undergoing a period of significant innovation and rapid 
modernisation, including a fundamental shift away from the use of traditional pre-determined dose 
distributions and a change from 2D to 3D perspectives of the entire treatment process. It is essential 
that quality assurance techniques keep pace with developments in brachytherapy treatment planning 
and delivery to ensure an appropriate level of dosimetric accuracy and quality. Traditional methods of 
quality control are based solely on isolated source-strength measurements with very little independent 
measurement of the actual dose delivery: This is inadequate for modern 3D-based brachytherapy 
which requires multi-dimension verification measurements of the dose delivered when using clinical 
treatment applicators and the potential of significant patient-specific dose distribution optimisation.  
There is however a lack of established methods for quality control measurements of 3D dose 
distribution delivered by HDR treatment equipment [1]. The measurement challenge in brachytherapy 
is particularly difficult due to extremely steep dose gradients (6% per mm at the target volume in HDR 
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gynaecology treatments) and orders of magnitude variation in dose deposition across the region of 
interest. Measurement systems must also be sufficiently flexible to accept a range of HDR applicator 
designs and provide data within the maximum extent of the applicator dimensions. 
Radiochromic film has been used in brachytherapy dosimetry by many investigators over the last 
decade to make specific measurements or to verify Monte Carlo generated TG43-based source model 
data [2-4]. However there have been no publications to date utilising the latest Gafchromic EBT3 
radiochromic film in brachytherapy applications. There have also been only limited publications on 
quality control audit methods for brachytherapy dosimetry, all being based on point dose 
measurements, normally with ion chambers or alanine [5-7]. Further development of practical 
measurement and analysis techniques is required both for routine in-clinic quality checks of 
brachytherapy equipment performance and for independent 3D brachytherapy dosimetry audits. 
We present a novel film-array test object using EBT3 film and multi-channel dosimetric analysis, 
suitable for use in quality control or quality audit measurements in HDR brachytherapy. We also 
evaluate the EBT3 manufacture’s useable dose range statement “1 cGy to > 40 Gy”, which is 
particularly relevant for brachytherapy applications [8]. 
2.  Methods and materials 
All measurements were performed using Gafchromic EBT3 (ISP Advanced Materials, New Jersey, 
USA) from a single batch. HDR exposures were performed with the Eckert & Ziegler BEBIG GmbH 
MultiSource® HDR treatment unit with a Co-60 source. Films were scanned using a 48-bit rgb 
transmission film scanner (Epson Perfection V750 Pro) at 96 dpi with no colour or sharpness 
corrections and consistent orientation and time-since-exposure protocol. Images were analysed in three 
colour channels using FilmQAPro® software (ISP Advanced Materials, New Jersey, USA). Treatment 
planning system (TPS) dose calculations were made with the Eckert & Ziegler BEBIG GmbH HDR 
Plus® software, utilizing a TG-43 based dose calculation. 
2.1.  EBT3 calibration 
The dose response of the EBT3 film was evaluated by exposing 5 cm width strips positioned on the 
central axis in a 10 x 10 cm treatment field from a 6 MV linear accelerator (linac) treatment unit, to 
doses from 0 to 90.7 Gy. The output of the linac having been measured immediately preceding the 
EBT3 exposures, with three ionization chambers with calibrations traceable to a primary standard held 
at the National Physical Laboratory, Teddington, UK. 
2.2.  Film-array measurements 
The film-array water phantom is shown in figure 1. A three-sided Perspex holder was accurately 
machined to precisely locate parallel EBT3 films in water, eleven central films at 5.0 mm separation, 
and three outer films at 10.0 mm separation. The holder was positioned centrally within a 50 litre 
water tank to provide near full scatter conditions. A clamp and stand was used to position the HDR 
applicator within the film array using alignment guides. Symmetric films at the same distance from the 
applicator (left and right) were used as consistency checks of the applicator and film alignment. 
2.2.1.  Single dwell point measurement. The dosimetry system was validated by measuring the dose 
with radial distance from a single source, repeating the measurement with three separate films, and 
comparing results to previously published Monte Carlo generated TG43 dose model parameters [9] 
and treatment planning system predicted dose points.  
2.2.2.  Clinical treatment applicator measurement. The dose distribution in several 2D planes around a 
clinical cervix applicator (Eckert & Ziegler BEBIG ring and intrauterine (IU) tube) was measured 
using the EBT3 film-array phantom: This enabled a semi-3D verification of the intended dose 
distribution. These images were compared to the isodose distribution calculated by the treatment 
planning system.  
7th International Conference on 3D Radiation Dosimetry (IC3DDose) IOP Publishing
Journal of Physics: Conference Series 444 (2013) 012101 doi:10.1088/1742-6596/444/1/012101
2
  
 
. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Film-array 
holder with four EBT3 
films in place around 
cervix treatment 
applicator (a) prior to 
irradiation and (b) in 
water connected to HDR 
treatment unit, post 
irradiation 
 
3.  Results 
Figure 2 shows the EBT3 colour channel response as a function of dose and the applied cubic 
calibration fit to the red, green and blue channels over a 0 to 90 Gy range. Figure 3 shows the 
calibrated film dose response for the red and green channels as a function of radial distance in the case 
of a single isolated source, compared to TPS and Monte Carlo calculation. Figure 4 shows an isodose 
comparison of the EBT3 measured and TPS calculated dose distributions in a plane 1 cm above the IU 
channel of the clinical applicator. In general distance to agreement between the sets of isodose lines is 
within 4 mm. 
 
 
Figure 2: Calibration fit of red, green & blue film  Figure 3: EBT3 measured dose compared to  
channels, over 0 to 90 Gy, using FilmQAPro® TPS and Monte Carlo from single source 
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Figure 4: Comparison of EBT3 
measured (thin lines) and TPS 
calculated (thick lines) isodose 
distribution, 50 to 250 %, for 8.5 Gy 
prescription dose. 
 
 
 
4.  Conclusions and Discussion 
The use of Gafchromic EBT3 film for brachytherapy applications has been successfully demonstrated, 
with a calibration curve up to 90 Gy established. The film measurement technique has been 
successfully validated for the case of a single dwell against TPS and Monte Carlo data. Film 
measurements in multiple planes around an HDR cervix treatment applicator have shown acceptable 
agreement with TPS, generally within 4 mm distance to agreement within each plane. Distance to 
agreement can also be assessed between the multiple film planes (semi-3D analysis). 
The EBT3 film-array water phantom has applications as a routine quality control tool, a non-
routine commissioning system for new applicators or source models, or as an independent quality 
audit system, providing semi-3D verification of the actual dose distribution delivered by HDR 
treatment equipment, in difficult measurement situations. 
5.  Acknowledgments 
The authors gratefully acknowledge Vertec UK for the supply of EBT3 film used in this investigation, 
and Steve Craig at the University of Surrey for construction of the film array phantom. 
6.  References 
[1] Palmer A et al 2012 J. Contemp. Brachyther. 4 81-91 
[2] Sureka C S et al 2007 Phys. Med. Biol. 2007 52 525-37 
[3] Lliso F et al 2011 J. Contemp. Brachyther. 3 32-5 
[4] Aldelaijan S et al 2011 Med. Phys. 38 6074-83 
[5] Elfrink R J M et al 2011 Radiother. Oncol. 2001 59 297-306 
[6] Roué A et al 2007 Radiother. Oncol. 83 86-93 
[7] Carlsson Tedgren A and Grindborg J E 2008 Radiother. Oncol. 2008 86 126-30 
[8] International Specialty Products Advanced Materials (ISP), New Jersey, USA. Gafchromic 
EBT3 brochure 2011 
[9] Granero D et al 2007 Med. Phys. 34 3485-8 
 
7th International Conference on 3D Radiation Dosimetry (IC3DDose) IOP Publishing
Journal of Physics: Conference Series 444 (2013) 012101 doi:10.1088/1742-6596/444/1/012101
4
